USFDA nod to Pfizer Braftovi Combination Regimen for BRAF V600E-Mutant Metastatic Colorectal Cancer Ruchika Sharma21 Dec 2024 2:30 PM ISTNew York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI (encorafenib) in combination with...
From Cancer Medicines to Insulins: AIIMS Expands Free Medication List Kajal Rajput20 Oct 2023 1:40 PM ISTAIIMS Delhi has expanded its list of free medications by adding 63 more drugs, bringing the total to 359. This move aims to enhance healthcare...
Chemoradiotherapy may be safely omitted in some patients with locally advanced rectal cancer: PROSPECT trial Medha Baranwal11 Jun 2023 8:00 PM ISTUSA: Findings from the PROSPECT trial have shown preoperative FOLFOX to be non-inferior to preoperative chemoradiotherapy for disease-free survival...
Folfirinox prolongs survival in individuals with resected pancreatic ductal adenocarcinoma: Study Dr. Kamal Kant Kohli7 Sept 2022 6:15 AM ISTFRANCE: Patients with resected pancreatic ductal adenocarcinoma experience significantly longer survival with modified FOLFIRINOX compared with...
